Golden molecular helix of glowing spheres floating in deep violet space

Longevity Clinic PPC Built Around Membership Economics

Rank & Rejuvenate runs Google Ads for longevity clinics where the unit of success is a booked consult that converts to a member, not a click. Appointment-level attribution, policy-fluent healthcare campaigns, month to month.

Why PPC math is unforgiving in this vertical

A longevity clinic does not sell a visit. It sells a membership, commonly $700 to $1,200 per month, which means a single converted consult can be worth $8,400 to $14,400 in first-year recurring revenue. Industry reporting puts average patient acquisition cost for wellness practices near $285 to $312 against a first-visit ticket commonly cited around $536, so the economics only work when the click becomes a consult, the consult shows, and the patient converts to a member.

Generic PPC management ignores all of that. It optimizes toward the cheapest click, which in this category is usually a peptide researcher, a price shopper, or someone looking for compounded product without a clinical relationship. Meanwhile consultants report clinics running at roughly 40 percent capacity with fixed overhead that does not wait, so every wasted dollar of spend is a membership slot that stayed empty.

The question a campaign has to answer is not how many people clicked. It is which keyword, ad, and landing page put a member on the schedule, and at what cost.

What we build and run

We structure the account around your highest-LTV protocols, not around whatever Google's automation drifts toward. Peptide therapy, hormone optimization, TRT, comprehensive panels, and membership consults each get their own campaigns, budgets, and landing pages, because a search for a $1,000 per month membership and a search for a single lab draw deserve different bids and different pages.

Just as much effort goes into what we exclude. Negative keyword sets strip out DIY peptide buyers, research-chemical traffic, and insurance-seeking queries before they spend your budget, and geographic targeting reflects the radius an affluent cash-pay member will actually drive.

Every landing page states what the clinic does, who leads it, and what the protocol involves before asking for anything, with online scheduling wired in so the consult books immediately. Reporting shows that speed matters here. Commonly cited benchmarks suggest most callers who hit voicemail never call back, so we route form fills and calls for immediate follow-up rather than a next-day queue.

Campaigns segmented by protocol: peptides, hormone optimization, TRT, panels, membership consults
Negative keyword architecture that blocks research-chemical and DIY-peptide traffic
Landing pages built for the evidence-first buyer, not hype
Online booking and call routing wired for speed to consult
Budget weighted toward the protocols with the highest member LTV

Measured at the appointment, not the click

Our reporting unit is cost per booked patient. Call tracking, form attribution, and scheduling data connect each consult on your calendar back to the keyword and ad that produced it, so you can see which campaigns fill membership slots and which only generate activity.

The tracking layer is built for healthcare from the start. Standard pixel setups are a liability in this category after regulators put health-data tracking on notice and platforms began restricting sensitive health events, so we implement compliant server-side measurement that attributes revenue without exposing patient data.

Then there is the 60-second test. Open your report, and within a minute you should know how many consults were booked, what each one cost, and which protocol they asked about. If a report needs a meeting to explain it, it is hiding something.

Platform policy fluency is the edge

Healthcare advertisers now operate under rules that quietly break amateur accounts. Meta's late 2025 health-advertiser tiering blocks lead and purchase conversion events for many clinics, and Google applies its own health personalization restrictions. Industry reporting also counts more than 80 FDA warning letters to telehealth companies over compounded GLP-1 marketing in a single year, which means ad copy itself is a licensing risk when written by a generalist.

We write and structure ads to survive both the platform review and a regulator's read. No sameness claims against branded drugs, no guarantee language, no anti-aging hype that trips disapprovals, and evidence-framed copy that matches how your clinicians actually talk about protocols.

We are also honest about sequencing. Industry reporting puts organic search CAC meaningfully below paid social for patient acquisition, so ads are the fast channel while organic authority compounds underneath. We run PPC to fill the schedule now and expect its share of your acquisition mix to shrink as organic takes over the cheapest ground. An agency that wants your ad spend to grow forever is not on your side of the table.

Ad copy reviewed against FDA compounding enforcement patterns and FTC substantiation standards
Meta health-tier and Google health-policy navigation built into account structure
No sameness claims, no guarantees, no anti-aging hype
Honest ads-now, organic-compounds sequencing with a declining paid dependency

Questions practice owners ask

How fast does longevity clinic PPC produce booked consults?

Campaigns typically start producing booked consults within the first few weeks, since paid search intercepts people already searching for peptide therapy, hormone optimization, or a longevity clinic near them. What takes longer is optimization: the first 60 to 90 days refine which protocols, keywords, and pages produce members rather than inquiries. We pair this with organic work because ads buy speed while search authority compounds, and over time the cheaper channel should carry more of the load.

How is this different from the last agency we paid?

Three structural differences. We report cost per booked patient, not impressions, clicks, or raw inquiry counts, and we track what happens after the form fill instead of declaring victory at the click. We work month to month, so the contract does not protect us from our own results. And you own everything: the ad account, the tracking, the landing pages, all of it stays yours if you leave.

Can you advertise peptide and GLP-1 protocols without regulatory risk?

Yes, within the rules, and the rules are real. FDA enforcement against compounded GLP-1 marketing has been aggressive, so we never write sameness claims against branded drugs, never use guarantee language, and keep copy evidence-framed rather than promotional. On the platform side we structure accounts around Meta's health-advertiser tiers and Google's health policies, and we use compliant server-side tracking so measurement does not create a HIPAA exposure. The compliance burden sits on your license, so we write as if a regulator reads every ad.

Your schedule, predictable

Start with a free growth audit: your rankings, your reviews, your booking flow, and exactly where the patients are going instead. No contract. No pitch deck.